SCHEMBL6036786

SCHEMBL6036786

C[C@@H]1NC(=O)N[C@@H]1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3384844 1.00
SCHEMBL13233500 0.80 TSHR (0.38)
SCHEMBL11680526 0.78 TSHR (0.35)
SCHEMBL7611377 0.77
SCHEMBL19067687 0.76 TDP1 (0.33)
SCHEMBL36249 0.75 MAPT (0.39)
SCHEMBL36250 0.75 MAPT (0.39)
SCHEMBL10110596 0.74
SCHEMBL15999201 0.74 TDP1 (0.32)
SCHEMBL16234658 0.74 TDP1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030129191-A1 Pretargeting methods and compounds NEORX CORPORATION (US) 2003-07-10 US claimed
US-6416738-B1 ADMINISTERING TO A RECIPIENT A FIRST CONJUGATE COMPRISING A TARGETING MOIETY AND A MEMBER OF A LIGAND/ANTI-LIGAND BINDING PAIR, THEREAFTER ADMINISTERING TO THE RECIPIENT A CLEARING AGENT, ADMINISTERING SECOND CONJUGATE NEORX CORPORATION 2002-07-09 US claimed
US-6075010-A Small molecular weight ligand-hexose containing clearing agents NEORX CORPORATION (US) 2000-06-13 US claimed
EP-0743956-A4 PRETARGETING METHODS AND COMPOUNDS NEORX CORP (US) 1999-03-24 EP claimed
US-5624896-A Clearing agents useful in pretargeting methods NEORX CORPORATION (US) 1997-04-29 US claimed
EP-0743956-A1 PRETARGETING METHODS AND COMPOUNDS NeoRx (US) 1996-11-27 EP claimed
WO-1995015978-A1 PRETARGETING METHODS AND COMPOUNDS NEORX CORPORATION (US) 1995-06-15 WO claimed
US-20090018777-A1 Systems and Methods for Predicitng Ligand-Protein Binding Interactions HRNCIAR PETER 2009-01-15 US disclosed
US-20090018777-A1 Systems and Methods for Predicitng Ligand-Protein Binding Interactions HRNCIAR PETER 2009-01-15 US disclosed
US-20090006040-A1 Systems and Methods for Representing Protein Binding Sites and Identifying Molecules with Biological Activity HRNCIAR PETER 2009-01-01 US disclosed
US-20090006040-A1 Systems and Methods for Representing Protein Binding Sites and Identifying Molecules with Biological Activity HRNCIAR PETER 2009-01-01 US disclosed
US-20080319677-A1 Systems and Methods for Designing Molecules with Affinity for Therapeutic Target Proteins HRNCIAR PETER 2008-12-25 US disclosed
US-20080319677-A1 Systems and Methods for Designing Molecules with Affinity for Therapeutic Target Proteins HRNCIAR PETER 2008-12-25 US disclosed
WO-1997046098-A1 CLUSTER CLEARING AGENTS NEORX CORPORATION (US) 1997-12-11 WO disclosed
WO-1997046099-A1 LIVER RETENTION CLEARING AGENTS NEORX CORPORATION (US) 1997-12-11 WO disclosed
EP-0794788-A1 HEPATIC-DIRECTED COMPOUNDS AND REAGENTS FOR PREPARATION THEREOF NEORX CORPORATION (US) 1997-09-17 EP disclosed
US-5624896-A Clearing agents useful in pretargeting methods NEORX CORPORATION (US) 1997-04-29 US disclosed
EP-0743956-A1 PRETARGETING METHODS AND COMPOUNDS NeoRx (US) 1996-11-27 EP disclosed
WO-1996017613-A1 HEPATIC-DIRECTED COMPOUNDS AND REAGENTS FOR PREPARATION THEREOF NEORX CORPORATION (US) 1996-06-13 WO disclosed
WO-1995015978-A1 PRETARGETING METHODS AND COMPOUNDS NEORX CORPORATION (US) 1995-06-15 WO disclosed